WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell deathMarcus Fischer, Timothy Hoey, Belinda Cancilla et al.|Science Advances|2017Cited by 156
Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCécile Chartier, Austin Gurney, Marcus Fischer et al.|Cancer Research|2016Cited by 115
Abstract 4367: Discovery and evaluation of pharmacodynamic and predictive biomarkers for anti-RSPO3, a treatment that reduces tumor growth and cancer stem cell frequency in patient derived xenograft tumor modelsFiore Cattaruzza, Ann M. Kapoun, Pete Yeung et al.|Cancer Research|2015Cited by 1
Figures S1-S7 from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCécile Chartier, Austin Gurney, Janak Raval et al.|Unknown|2023Cited by 0
Tables S1-S3 from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCécile Chartier, Austin Gurney, Janak Raval et al.|Unknown|2023Cited by 0